Mason Street Advisors’s Adient ADNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-50,146
Closed -$1.74M 32
2020
Q4
$1.74M Sell
50,146
-102
-0.2% -$2.88K 0.03% 702
2020
Q3
$871K Buy
50,248
+2,404
+5% +$41.9K 0.02% 875
2020
Q2
$786K Buy
47,844
+1,544
+3% +$23.5K 0.02% 921
2020
Q1
$420K Hold
46,300
0.01% 1047
2019
Q4
$984K Buy
46,300
+640
+1% +$14.2K 0.02% 890
2019
Q3
$1.05M Sell
45,660
-705
-2% -$16.1K 0.02% 832
2019
Q2
$1.13M Buy
46,365
+109
+0.2% +$2.24K 0.02% 809
2019
Q1
$599K Buy
46,256
+760
+2% +$13.3K 0.01% 1075
2018
Q4
$685K Buy
45,496
+896
+2% +$23.2K 0.02% 942
2018
Q3
$1.75M Buy
+44,600
New +$2.01M 0.04% 648

Other funds holding ADNT

Mason Street Advisors's ADNT Position: Q1 2021 in Review

Mason Street Advisors sold out of Adient (ADNT) in Q1 2021, closing a stake of 50,146 shares — an estimated $1.74M sold.

Mason Street Advisors first reported a position in ADNT in Q3 2018 and held it in 10 quarters. The position peaked at $1.75M in Q3 2018. 301 funds tracked by Wall St. Rank hold ADNT as of Q1 2021.

  • Mason Street Advisors reported no remaining Adient position as of Q1 2021 after selling out during the quarter.
  • Mason Street Advisors sold 50,146 Adient shares in Q1 2021, an estimated $1.74M.
  • Mason Street Advisors first reported a position in Adient in Q3 2018 and held it in 10 quarters.
  • Mason Street Advisors's Adient position peaked at $1.75M in Q3 2018.
  • 301 funds tracked by Wall St. Rank held Adient as of Q1 2021.

Based on Mason Street Advisors's 13F filing for Q1 2021, filed 14 May 2021.